Category I indications: Supported
by the strongest evidence or expert opinion; TEE is frequently useful in improving
clinical outcomes in the following settings and is often indicated, depending on
individual circumstances: |
Intraoperative evaluation of acute, persistent, and life-threatening
hemodynamic disturbances in which ventricular function and its determinants are uncertain
and have not responded to treatment |
Intraoperative use in valve repair |
Intraoperative use in congenital heart surgery for most lesions
requiring cardiopulmonary bypass |
Intraoperative use in repair of hypertrophic obstructive cardiomyopathy |
Intraoperative use for endocarditis when preoperative testing
was inadequate or extension of infection to perivalvular tissue is suspected |
Preoperative use in unstable patients with suspected thoracic
aortic aneurysms, dissection, or disruption who need to be evaluated quickly |
Intraoperative assessment of aortic valve function in repair
of aortic dissections with possible aortic valve involvement |
Intraoperative evaluation of pericardial window procedures |
Use in the intensive care unit for unstable patients with unexplained
hemodynamic disturbances, suspected valve disease, or thromboembolic problems (if
other tests or monitoring techniques have not confirmed the diagnosis or patients
are too unstable to undergo other tests) |
Category II indications: Supported
by weaker evidence and expert consensus; TEE may be useful in improving clinical
outcomes in the following settings, depending on individual circumstances, but appropriate
indications are less certain: |
Perioperative use in patients with an increased risk of myocardial
ischemia or infarction |
Perioperative use in patients with an increased risk of hemodynamic
disturbances |
Intraoperative assessment of valve replacement |
Intraoperative assessment of repair of cardiac aneurysms |
Intraoperative evaluation of removal of cardiac tumors |
Intraoperative detection of foreign bodies |
Intraoperative detection of air emboli during cardiotomy, heart
transplant operations, and upright neurosurgical procedures |
Intraoperative use during intracardiac thrombectomy |
Intraoperative use during pulmonary embolectomy |
Intraoperative use for suspected cardiac trauma |
Preoperative assessment of patients with suspected acute thoracic
aortic dissections, aneurysms, or disruption |
Intraoperative use during repair of thoracic aortic dissections
without suspected aortic valve involvement |
Intraoperative detection of aortic atheromatous disease or other
sources of aortic emboli |
Intraoperative evaluation of pericardiectomy, pericardial effusions,
or pericardial surgery |
Intraoperative evaluation of anastomotic sites during heart and/or
lung transplantation |
Monitoring placement and function of assist devices |
Category III indications: Little
current scientific or expert support; TEE is infrequently useful in improving clinical
outcomes in the following settings, and appropriate indications are uncertain: |
Intraoperative evaluation of myocardial perfusion, coronary artery
anatomy, or graft patency |
Intraoperative use during repair of cardiomyopathies other than
hypertrophic obstructive cardiomyopathy |
Intraoperative use for uncomplicated endocarditis during noncardiac
surgery |
Intraoperative monitoring for emboli during orthopedic procedures |
Intraoperative assessment of repair of thoracic aortic injuries |
Intraoperative use for uncomplicated pericarditis |
Intraoperative evaluation of pleuropulmonary diseases |
Monitoring placement of intra-aortic balloon pumps, automatic
implantable cardiac defibrillators, or pulmonary artery catheters |
Intraoperative monitoring of cardioplegia administration |
Adapted from Practice guidelines for perioperative transesophageal
echocardiography. A report by the American Society of Anesthesiologists and the
Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography.
Anesthesiology 84:986–1006, 1996. |